From Our Own Borealis Blog

How Canada combats antimicrobial resistance

pills

By Nahomi Amberber, Policy & Politics Co-Editor Do you remember how many times you’ve been prescribed an antibiotic or used […]

Continue reading


Blog Feeds

Creators – Miles van Yperen

Name: Miles van Yperen Which came first in your life, the science or the art? Art came first. I started with traditional media: pencils, watercolours, screen printing, and metal sculpture. When desktop computers and software became available I started with the first basic Mac black and white graphic programs, and worked in desktop publishing for years. From the 2D digital art world, I wanted to explore 3D once applications became available to the public. I purchased…

Continue reading


Life onboard our polar expedition

Much has happened in our 8 day transit from New Zealand to Antarctica. We learned about each other’s science and how we will work together in the coming weeks, hearing talks and taking tours. We crossed the Antarctic Circle and the Prime Meridian, and celebrated co-chief scientist Rob McKay’s birthday with a surprise party. Some were seasick through the Southern Ocean waves but we all made it. The Nathaniel B. Palmer escorted us through some...…

Continue reading


Life onboard our polar expedition

Much has happened in our 8 day transit from New Zealand to Antarctica. We learned about each other’s science and how we will work together in the coming weeks, hearing talks and taking tours. We crossed the Antarctic Circle and the Prime Meridian, and celebrated co-chief scientist Rob McKay’s birthday with a surprise party. Meals have been good, the gym frequented, sleep cherished. And during the transit we settled into life aboard ship. The ship...…

Continue reading


There’s no such thing as “an unrelated genus”

 Image: Osmia rufa, André Karwath, CC BY-SA 2.5; Boletus edulis, Hans Hillewaert, CC BY-SA 4.0; Volvocales, Aurora M. Nedelcu, CC BY 2.5; Chimp, Aaron Logan, CC BY 2.5; Ranunculus asiaticus, Leif Stridvall, CC BY-SA 2.5; Isotricha intestinalis, Agricultural Research Service/USDA CC 0; Compilation, Vojtěch Dostál, CC BY-SA 2.5.  (My writing pet peeves, part 4) There […]

Continue reading


There’s no such thing as “an unrelated genus”

 Image: Osmia rufa, André Karwath, CC BY-SA 2.5; Boletus edulis, Hans Hillewaert, CC BY-SA 4.0; Volvocales, Aurora M. Nedelcu, CC BY 2.5; Chimp, Aaron Logan, CC BY 2.5; Ranunculus asiaticus, Leif Stridvall, CC BY-SA 2.5; Isotricha intestinalis, Agricultural Research Service/USDA CC 0; Compilation, Vojtěch Dostál, CC BY-SA 2.5.  (My writing pet peeves, part 4) There […]

Continue reading


Sprinkling some Grains of Salt on Ice Bridge

Pic: Still from the documentary On January 14th, 2018, the popular CBC program “The Nature of Things” aired an hour-long documentary titled, Ice Bridge. This documentary sought out to explore in detail the Solutrean Hypothesis, the brain-child of archaeologists Dennis Stanford and Bruce Bradley. Well, in fairness the hypothesis came about in the 1930’s but quickly died out. Stanford and Bradley have since resurrected it. This hypothesis states that the first people to settle in the…

Continue reading


CRISPR-CAS9 and gold

As so often happens in the sciences, now that the initial euphoria has expended itself problems (and solutions) with CRISPR ((clustered regularly interspaced short palindromic repeats))-CAAS9 are being disclosed to those of us who are not experts. From an Oct. 3, 2017 article by Bob Yirka for phys.org, A team of researchers from the University of California and the University of Tokyo has found a way to use the CRISPR gene editing technique that does…

Continue reading


Explaining the hype: CAR T-cells

With the start of a new year, I like to take a moment to think about what things in cancer research got me really excited the previous year. Beyond a doubt, that thing for me in 2017 was the first (and second!) FDA approval of a CAR T-cell (chimeric antigen receptor T-cell) therapy as a treatment option for certain cancers. I am particularly excited about these leaps forward for cancer treatment options, as I used…

Continue reading